ArticleRheumatology (Oxford, England)2025

Potential impact of European Medicines Agency measures to minimize risk of serious side effects on JAKi prescribing and utilization in the UK.

Zixing Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.